The nation of Zimbabwe has turned down a substantial US health deal worth 367 million US dollars (272 million pounds) over five years due to the United States' insistence on sensitive information.
This rejection came to light following a government memo from December was disclosed, which showed Head of State Emmerson Mnangagwa believed the arrangement was "lopsided".
A government spokesperson later explained that the United States was demanding access to genetic material for research and commercial purposes but was not willing to guarantee the resulting advantages from future vaccines.
"We will now turn to the challenging and unfortunate task of ending our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy noted the US had furnished more than $1.9bn for health programmes to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has called for continued dialogue to secure a agreement suitable to all parties so the country's critical HIV programme can continue.
Wider Implications
This rejection comes after a comparable case in Kenya, where a court halted a similar deal with the US following legal challenges were filed about the safety of Kenyans' medical information.
Since resuming office recently, US President Donald Trump has slashed overseas assistance and shut down the key foreign aid agency.
USAID had managed assistance for the US government, but Trump argued its spending was "inefficient" and his government was pursuing direct bilateral deals to boost openness and responsibility.
As per statements, Sixteen African countries have so far agreed to these new health pacts, constituting over $18.3bn in new funding.
Details of the Rejected Agreement
The money for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this partnership would have delivered extraordinary advantages for the people of Zimbabwe, especially the 1.2 million currently on HIV treatment through American-funded programmes," the Ambassador added.
However, official spokesman Nick Mangwana maintained the arrangement was "unequal".
"The proposal required Zimbabwe to surrender its genetic material and health information indefinitely, without any equivalent assurance of benefiting from any medical innovations – such as new medicines or tests – that could result from that provided information," Mangwana explained.
"Put simply, our country would provide the basic resources for medical research without any certainty that the final treatments would be accessible to our citizens should a future disease outbreak arise."
National Interest and International Frameworks
He also noted that the American exit from the global health body and its push of one-on-one deals were upending systems already set up through the international health agency.
The spokesperson cited its Pathogen Access and Benefit Sharing framework designed to manage future global health emergencies.
"This system is intended to guarantee that when a country provides its samples, the resulting advantages – including medicines and cures – are distributed fairly, not commercialised solely by those with the resources to create them."
The government's concerns regarding the US deal "must not be interpreted as opposition to America," Mangwana stressed.
"We welcome further dialogue with our American counterparts on how future co-operation could be structured in a manner that respects the independence and dignity of both nations."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it acknowledged the government's concerns, but recommended that negotiations need to persist considering much of the country's Aids initiatives depended on international support.
"In cases where specific concerns exist, including those involving information security or implementation frameworks, these can often be addressed through technical clarification and negotiated safeguards," it added.
The halted deal emphasises the ongoing tensions between receiving much-needed international aid and safeguarding local interests in an increasingly interconnected world.